Distribution of c-Fos immunoreactivity in the rat brain following abuse-like toluene vapor inhalation

Neurotoxicology and Teratology

Volumn 34, Issue 1, 2012, Pages 37-46

  Perit, Kristina E ^a   Gmaz, Jimmie M ^a   Caleb Browne, J D ^a   Matthews, Brittany A ^a   Dunn, Mary Beth F ^a   Yang, Linda ^a   Raaphorst, Tanya ^a   Mallet, Paul E ^a   McKay, Bruce E ^a  

^a WILFRID LAURIER UNIVERSITY   (Canada)

Author keywords

Brain; C Fos; Immunohistochemistry; Rat; Toluene; Vapor

Indexed keywords

PROTEIN C FOS; TOLUENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN STEM; BRAIN TISSUE; CAUDATE NUCLEUS; CELL ACTIVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMOTIONALITY; HIPPOCAMPUS; IMMUNOREACTIVITY; INHALATION; MALE; MICROMORPHOLOGY; MOTOR CONTROL; MOTOR CORTEX; NERVE STIMULATION; NONHUMAN; PONS ANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PUTAMEN; PYRIFORM CORTEX; RAT; REWARD; THALAMUS NUCLEUS; VAPOR; VENTRAL TEGMENTUM;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INHALANT ABUSE; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; TOLUENE;

RATTUS;

EID: 82655178417     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.10.007     Document Type: Article

References (61)

1. Bading H., Ginty D.D., Greenberg M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993, 260:181-186.
2. Bale A.S., Smothers C.T., Woodward J.J. Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene. Br J Pharmacol 2002, 137:375-383.
3. Bale A.S., Tu Y., Carpenter-Hyland E.P., Chandler L.J., Woodward J.J. Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience 2005, 130:197-206.
4. Balster R.L. Neural basis of inhalant abuse. Drug Alcohol Depend 1998, 51:207-214.
5. Beckley J.T., Woodward J.J. The abused inhalant toluene differentially modulates excitatory and inhibitory synaptic transmission in deep-layer neurons of the medial prefrontal cortex. Neuropsychopharmacology 2011, 36:1531-1542.
6. Beckstead M.J., Weiner J.L., Eger E.I., Gong D.H., Mihic S.J. Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 2000, 57:1199-1205.
7. Benignus V.A., Boyes W.K., Bushnell P.J. A dosimetric analysis of behavioral effects of acute toluene exposure in rats and humans. Toxicol Sci 1998, 43:186-195.
8. Bernstein J., Adlaf E.M., Paglia-Boak A. Drug use in Toronto 2004, Toronto, Research Group on Drug Use.
9. Blokhina E.A., Dravolina O.A., Bespalov A.Y., Balster R.L., Zvartau E.E. Intravenous self-administration of abused solvents and anesthetics in mice. Eur J Pharmacol 2004, 485:211-218.
10. Bowen S.E., Batis J.C., Paez-Martinez N., Cruz S.L. The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 2006, 28:636-647.
11. Bukowski J.A. Review of the epidemiological evidence relating toluene to reproductive outcomes. Regul Toxicol Pharmacol 2001, 33:147-156.
12. Canales J.J. Catalase-independent early-gene expression in rat brain following acute ethanol exposure. Brain Res 2004, 1016:96-101.
13. Cao J., Lotfipour S., Loughlin S.E., Leslie F.M. Adolescent maturation of cocaine-sensitive neural mechanisms. Neuropsychopharmacology 2007, 32:2279-2289.
14. Chang S.L., Patel N.A., Romero A.A. Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration. Brain Res 1995, 679:89-98.
15. Cruz S.L., Mirshahi T., Thomas B., Balster R.L., Woodward J.J. Effects of the abused solvent toluene on recombinant N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 1998, 286:334-340.
16. Cruz S.L., Orta-Salazar G., Gauthereau M.Y., Millan-Perez Pena L., Salinas-Stefanon E.M. Inhibition of cardiac sodium currents by toluene exposure. Br J Pharmacol 2003, 140:653-660.
17. De Leonibus E., Mele A., Oliverio A., Pert A. Distinct pattern of c-fos mRNA expression after systemic and intra-accumbens amphetamine and MK-801. Neuroscience 2002, 115:67-78.
18. Edling Y., Ingelman-Sundberg M., Simi A. Glutamate activates c-fos in glial cells via a novel mechanism involving the glutamate receptor subtype mGlu5 and the transcriptional repressor DREAM. Glia 2007, 55:328-340.
19. Erdtmann-Vourliotis M., Mayer P., Riechert U., Hollt V. Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine). Brain Res Mol Brain Res 1999, 71:313-324.
20. Evans E.B., Balster R.L. CNS depressant effects of volatile organic solvents. Neurosci Biobehav Rev 1991, 15:233-241.
21. Festa E.D., Cecala C., Quinones-Jenab V., Jenab S. Cocaine modulates mu-opioid receptor mRNA but not c-fos mRNA levels in primary cortical astrocytes. Brain Res Bull 2002, 58:285-288.
22. Filley C.M., Halliday W., Kleinschmidt-DeMasters B.K. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 2004, 63:1-12.
23. Gerasimov M.R., Schiffer W.K., Marstellar D., Ferrieri R., Alexoff D., Dewey S.L. Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 2002, 65:243-251.
24. Gordon G.R., Mulligan S.J., MacVicar B.A. Astrocyte control of the cerebrovasculature. Glia 2007, 55:1214-1221.
25. Grabus S.D., Glowa J.R., Riley A.L. Morphine- and cocaine-induced c-Fos levels in Lewis and Fischer rat strains. Brain Res 2004, 998:20-28.
26. Greenberg M.M. The central nervous system and exposure to toluene: a risk characterization. Environ Res 1997, 72:1-7.
27. Hayward M.D., Duman R.S., Nestler E.J. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res 1990, 525:256-266.
28. Ikeuchi Y., Hirai H. Toluene inhibits synaptic transmission without causing gross morphological disturbances. Brain Res 1994, 664:266-270.
29. Ikeuchi Y., Hirai H., Okada Y., Mio T., Matsuda T. Excitatory and inhibitory effects of toluene on neural activity in guinea pig hippocampal slices. Neurosci Lett 1993, 158:63-66.
30. Jacobs P.S., Taylor B.M., Bardgett M.E. Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801. Brain Res Dev Brain Res 2000, 122:91-95.
31. Labiner D.M., Butler L.S., Cao Z., Hosford D.A., Shin C., McNamara J.O. Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J Neurosci 1993, 13:744-751.
32. Lee D.E., Gerasimov M.R., Schiffer W.K., Gifford A.N. Concentration-dependent conditioned place preference to inhaled toluene vapors in rats. Drug Alcohol Depend 2006, 85:87-90.
33. Lo P.S., Chen H.H. Immunohistochemical localization of toluene-induced c-Fos protein expression in the rat brain. Toxicol Lett 2005, 157:151-160.
34. Lopreato G.F., Phelan R., Borghese C.M., Beckstead M.J., Mihic S.J. Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend 2003, 70:11-15.
35. Lubman D.I., Yucel M., Lawrence A.J. Inhalant abuse among adolescents: neurobiological considerations. Br J Pharmacol 2008, 154:316-326.
36. MacIver M.B. Abused inhalants enhance GABA-mediated synaptic inhibition. Neuropsychopharmacology 2009, 34:2296-2304.
37. Magnusson A.K., Sulaiman M.R., Dutia M.B., Tham R. Effects of toluene on tonic firing and membrane properties of rat medial vestibular nucleus neurones in vitro. Brain Res 1998, 779:334-337.
38. McClung C.A., Ulery P.G., Perrotti L.I., Zachariou V., Berton O., Nestler E.J. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 2004, 132:146-154.
39. McDonald G. First Nations and Inuit Regional Health Survey 1999, First Nations and Inuit Regional Health Survey National Steering Committee, Ottawa.
40. McGregor I.S., Arnold J.C., Weber M.F., Topple A.N., Hunt G.E. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. Brain Res 1998, 802:19-26.
41. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 1991, 14:421-451.
42. Nakki R., Sharp F.R., Sagar S.M. FOS expression in the brainstem and cerebellum following phencyclidine and MK801. J Neurosci Res 1996, 43:203-212.
43. Nakki R., Sharp F.R., Sagar S.M., Honkaniemi J. Effects of phencyclidine on immediate early gene expression in the brain. J Neurosci Res 1996, 45:13-27.
44. Paglia-Boak A., Mann R.E., Adlaf E.M., Rehm J. Drug use among Ontario students 1977-2009 2009, Centre for Addiction and Mental Health, Toronto.
45. Pasumarthi R.K., Fadel J. Activation of orexin/hypocretin projections to basal forebrain and paraventricular thalamus by acute nicotine. Brain Res Bull 2008, 77:367-373.
46. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic Press, San Diego.
47. Reissig C.J., Rabin R.A., Winter J.C., Dlugos C.A. d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex. Eur J Pharmacol 2008, 583:40-47.
48. Riegel A.C., French E.D. An electrophysiological analysis of rat ventral tegmental dopamine neuronal activity during acute toluene exposure. Pharmacol Toxicol 1999, 85:37-43.
49. Riegel A.C., French E.D. Abused inhalants and central reward pathways: electrophysiological and behavioral studies in the rat. Ann N Y Acad Sci 2002, 965:281-291.
50. Riegel A.C., Zapata A., Shippenberg T.S., French E.D. The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology 2007, 32:1558-1569.
51. Rotllant D., Marquez C., Nadal R., Armario A. The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits. Neuroscience 2010, 168:691-705.
52. Salminen O., Seppa T., Gaddnas H., Ahtee L. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal. J Neurosci 1999, 19:8145-8151.
53. + channel function by volatile organic solvents. J Pharmacol Exp Ther 2005, 315:1109-1118.
54. Shram M.J., Funk D., Li Z., Le A.D. Acute nicotine enhances c-fos mRNA expression differentially in reward-related substrates of adolescent and adult rat brain. Neurosci Lett 2007, 418:286-291.
55. Spangler E., Cote D.M., Anacker A.M., Mark G.P., Ryabinin A.E. Differential sensitivity of the perioculomotor urocortin-containing neurons to ethanol, psychostimulants and stress in mice and rats. Neuroscience 2009, 160:115-125.
56. Subramanian S., Erokwu B., Han F., Dick T.E., Strohl K.P. L-NAME differentially alters ventilatory behavior in Sprague-Dawley and Brown Norway rats. J Appl Physiol 2002, 93:984-989.
57. Thiriet N., Aunis D., Zwiller J. C-fos and egr-1 immediate-early gene induction by cocaine and cocaethylene in rat brain: a comparative study. Ann N Y Acad Sci 2000, 914:46-57.
58. Tillar R., Shafer T.J., Woodward J.J. Toluene inhibits voltage-sensitive calcium channels expressed in pheochromocytoma cells. Neurochem Int 2002, 41:391-397.
59. Win-Shwe T.T., Fujimaki H. Neurotoxicity of toluene. Toxicol Lett 2010, 198:93-99.
60. Woodward J.J., Nowak M., Davies D.L. Effects of the abused solvent toluene on recombinant P2X receptors expressed in HEK293 cells. Brain Res Mol Brain Res 2004, 125:86-95.
61. Yagle K., Costa L.G. Effects of alcohol on immediate-early gene expression in primary cultures of rat cortical astrocytes. Alcohol Clin Exp Res 1999, 23:446-455.